Freeport (FCX) Stock Declined While Plante Moran Financial Advisors Has Lifted Position; Veritas Investment Management Llp Has Cut Its Thermo Fisher Scientific (TMO) Holding as Share Price Rose

May 19, 2018 - By Marie Mckinney

Freeport-McMoRan Inc. (NYSE:FCX) Logo

Veritas Investment Management Llp decreased its stake in Thermo Fisher Scientific Inc (TMO) by 6.34% based on its latest 2017Q4 regulatory filing with the SEC. Veritas Investment Management Llp sold 26,641 shares as the company’s stock rose 8.51% while stock markets declined. The institutional investor held 393,362 shares of the industrial machinery and components company at the end of 2017Q4, valued at $74.74 million, down from 420,003 at the end of the previous reported quarter. Veritas Investment Management Llp who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $86.48 billion market cap company. The stock increased 1.86% or $3.93 during the last trading session, reaching $214.94. About 1.07 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since May 19, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Plante Moran Financial Advisors Llc increased its stake in Freeport (FCX) by 2898.55% based on its latest 2017Q4 regulatory filing with the SEC. Plante Moran Financial Advisors Llc bought 20,000 shares as the company’s stock declined 4.75% with the market. The institutional investor held 20,690 shares of the basic industries company at the end of 2017Q4, valued at $392,000, up from 690 at the end of the previous reported quarter. Plante Moran Financial Advisors Llc who had been investing in Freeport for a number of months, seems to be bullish on the $24.44 billion market cap company. The stock increased 0.54% or $0.09 during the last trading session, reaching $16.87. About 16.11M shares traded. Freeport-McMoRan Inc. (NYSE:FCX) has risen 41.20% since May 19, 2017 and is uptrending. It has outperformed by 29.65% the S&P500.

Investors sentiment decreased to 0.91 in Q4 2017. Its down 0.05, from 0.96 in 2017Q3. It worsened, as 43 investors sold TMO shares while 410 reduced holdings. 93 funds opened positions while 319 raised stakes. 335.65 million shares or 0.74% more from 333.20 million shares in 2017Q3 were reported. Sterneck Capital has 0.4% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). 2.19 million are owned by Amundi Pioneer Asset Inc. Rosenblum Silverman Sutton S F Ca owns 3.02% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 44,324 shares. Cetera Advisor Ntwk Limited Company has 0.04% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Legacy Private owns 13,413 shares. Cap City Fl holds 1.34% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 16,764 shares. Endurant Limited Partnership has 2.53% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 43,608 shares. State Of Wisconsin Invest Board accumulated 633,861 shares. Soros Fund Management Llc has invested 0.25% in Thermo Fisher Scientific Inc. (NYSE:TMO). 60 are owned by Harding Loevner Limited Partnership. Moreover, Campbell & Communications Invest Adviser Ltd Com has 0.21% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 1,471 shares. Pillar Pacific Mgmt owns 58,285 shares. First Commonwealth Fincl Pa owns 6,892 shares. Cls Limited Liability Corporation accumulated 409 shares. Tekla owns 137,968 shares for 1.01% of their portfolio.

Since December 15, 2017, it had 0 insider buys, and 8 insider sales for $37.14 million activity. $1.05 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by Williamson Stephen. 50,000 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $9.59 million were sold by CASPER MARC N. Herrema Gregory J. sold $7.32 million worth of stock or 33,327 shares. Durbin Patrick M had sold 6,000 shares worth $1.31M.

More important recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Key events next week – healthcare” on May 18, 2018, also 247Wallst.com published article titled: “UBS Makes Big Health Care Swap in Top Performing Q-GARP Portfolio”, Streetinsider.com published: “Appaloosa 13F Shows New Stake in Wells Fargo (WFC) and Lam Research (LRCX), Increase in Micron (MU) MGM …” on May 15, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) was released by: Streetinsider.com and their article: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” with publication date: May 15, 2018.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on July, 25. They expect $2.69 earnings per share, up 16.96% or $0.39 from last year’s $2.3 per share. TMO’s profit will be $1.08 billion for 19.98 P/E if the $2.69 EPS becomes a reality. After $2.50 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 7.60% EPS growth.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 63 analyst reports since July 24, 2015 according to SRatingsIntel. Leerink Swann maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, October 9 with “Outperform” rating. Bank of America maintained the stock with “Buy” rating in Thursday, February 1 report. On Thursday, February 1 the stock rating was maintained by Jefferies with “Hold”. The company was maintained on Wednesday, April 11 by Morgan Stanley. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Friday, October 20 by Jefferies. The stock has “Overweight” rating by Barclays Capital on Tuesday, July 19. The firm has “Hold” rating by Jefferies given on Thursday, July 13. The rating was initiated by Argus Research with “Buy” on Tuesday, October 6. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, April 26. The rating was maintained by Leerink Swann with “Buy” on Monday, December 4.

Investors sentiment decreased to 0.92 in 2017 Q4. Its down 0.08, from 1 in 2017Q3. It is negative, as 77 investors sold FCX shares while 205 reduced holdings. 78 funds opened positions while 182 raised stakes. 989.88 million shares or 2.99% more from 961.13 million shares in 2017Q3 were reported. United Kingdom-based River And Mercantile Asset Mngmt Llp has invested 1.04% in Freeport-McMoRan Inc. (NYSE:FCX). State Of New Jersey Common Pension Fund D stated it has 3.35M shares. 15,327 were accumulated by Waters Parkerson Ltd Liability Corporation. Central Secs Corporation has 0.46% invested in Freeport-McMoRan Inc. (NYSE:FCX). 112,066 were reported by Reliance Tru Company Of Delaware. Patriot Wealth Mgmt holds 0.51% or 191,626 shares. 1,280 were reported by Hall Laurie J Trustee. Peak6 Lp invested in 953,378 shares or 0.08% of the stock. Poplar Forest Cap Lc holds 1.54 million shares or 2.33% of its portfolio. Legal & General Gru Plc invested in 7.20 million shares or 0.1% of the stock. Amer Century Inc has invested 0% in Freeport-McMoRan Inc. (NYSE:FCX). Ntv Asset Mgmt Ltd Llc has 32,140 shares. Hartford Fin has invested 0.03% in Freeport-McMoRan Inc. (NYSE:FCX). M&T Natl Bank Corporation reported 0.01% in Freeport-McMoRan Inc. (NYSE:FCX). Nuveen Asset Ltd Liability Corporation reported 122,072 shares stake.

Among 23 analysts covering Freeport-McMoran Copper & Gold (NYSE:FCX), 5 have Buy rating, 5 Sell and 13 Hold. Therefore 22% are positive. Freeport-McMoran Copper & Gold had 106 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Sunday, July 30 by RBC Capital Markets. Jefferies maintained Freeport-McMoRan Inc. (NYSE:FCX) on Wednesday, October 4 with “Buy” rating. The company was maintained on Tuesday, June 27 by BMO Capital Markets. The firm earned “Buy” rating on Monday, January 29 by Cowen & Co. The stock of Freeport-McMoRan Inc. (NYSE:FCX) has “Hold” rating given on Tuesday, February 6 by Stifel Nicolaus. The stock of Freeport-McMoRan Inc. (NYSE:FCX) has “Buy” rating given on Thursday, December 1 by UBS. The firm has “Neutral” rating given on Tuesday, February 21 by Citigroup. The firm has “Underperform” rating by Bank of America given on Wednesday, October 4. FBR Capital maintained Freeport-McMoRan Inc. (NYSE:FCX) rating on Thursday, September 14. FBR Capital has “Neutral” rating and $12 target. Jefferies maintained Freeport-McMoRan Inc. (NYSE:FCX) on Monday, April 9 with “Buy” rating.

Freeport-McMoRan Inc. (NYSE:FCX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: